Regenxbio Inc (RGNX)

Cash & Equivalents

$36.49M

Quarterly · Period ending: · USD

RGNX logo

RGNX Cash & Equivalents

Latest reported$34.47M
RGNX FY Cash & Equivalents ($1.12M → $34.47M)
High-resolution chart · PNG

RGNX cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
34,466,000
57,526,000
34,522,000
96,952,000
345,209,000
338,426,000
69,514,000
75,561,000
46,656,000
24,840,000
54,116,000
1,121,000
1,119,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.